A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
Clinical trial NCT02873208 · COMPLETED
Trial details
- NCT number
- NCT02873208
- Sponsor
- Alkermes, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-07
- Primary completion
- 2019-10-17
- Enrollment
- 266
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.